BPG is committed to discovery and dissemination of knowledge
Featured Articles
6/24/2022 7:24:50 AM | Browse: 320 | Download: 744
Publication Name World Journal of Translational Medicine
Manuscript ID 74949
Country/Territory India
Received
2022-01-12 06:24
Peer-Review Started
2022-01-12 06:26
To Make the First Decision
Return for Revision
2022-02-08 10:44
Revised
2022-03-05 14:27
Second Decision
2022-06-01 02:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-06-03 21:42
Articles in Press
2022-06-03 21:42
Publication Fee Transferred
Edit the Manuscript by Language Editor
2022-05-25 17:49
Typeset the Manuscript
2022-06-13 09:04
Publish the Manuscript Online
2022-06-24 07:19
ISSN 2220-6132 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Minireviews
Article Title Current progress and emerging technologies for generating extra-pancreatic functional insulin producing cells
Manuscript Source Unsolicited Manuscript
All Author List Md Aejaz Habeeb, Sandeep Kumar Vishwakarma, Safwaan Habeeb and Aleem Ahmed Khan
Funding Agency and Grant Number
Corresponding Author Md Aejaz Habeeb, MBBS, MD, PhD, Centre for Liver Research and Diagnostics, Deccan College of Medical Sciences, Kanchanbagh, DMRL X Road, Hyderabad 500058, Telangana, India. aejazhabeeb@hotmail.com
Key Words Diabetes mellitus; Cell-based therapy; Insulin producing cells; Extra-pancreatic sources; Biomaterials; Tissue engineering
Core Tip The currently accepted available treatment strategies for uncontrolled diabetes mellitus (DM) are pancreas and islet transplantation. However, these strategies are limited due to unavailability of quality pancreas/islet donors, life-long need of immunosuppressant and associated complications. Exogenous insulin administration is one of the clinically established options for the patients with type 1 DM. Liver could be an appropriate extra-pancreatic source to isolate produce number of insulin producing cells due to similar embryonic developmental origin. The furthermost need to develop more effective diabetes cell-based therapies lies in the advancements of robust sensitive micro and nanodevices for exogenous insulin-delivery.
Publish Date 2022-06-24 07:19
Citation Habeeb MA, Vishwakarma SK, Habeeb S, Khan AA. Current progress and emerging technologies for generating extrapancreatic functional insulin-producing cells. World J Transl Med 2022; 10(1): 1-13
URL https://www.wjgnet.com/2220-3230/full/v10/i1/1.htm
DOI https://dx.doi.org/10.5528/wjtm.v10.i1.1
Full Article (PDF) WJTM-10-1.pdf
Full Article (Word) WJTM-10-1.docx
Manuscript File 74949_Auto_Edited-JRF-Kerr C-LS.docx
Answering Reviewers 74949-Answering reviewers.pdf
Audio Core Tip 74949-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 74949-Conflict-of-interest statement.pdf
Copyright License Agreement 74949-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 74949-Language certificate.pdf
Peer-review Report 74949-Peer-review(s).pdf
Scientific Misconduct Check 74949-Bing-Fan JR-2.png
Scientific Editor Work List 74949-Scientific editor work list.pdf